Related Experiment Video
Updated: Mar 31, 2026

An Oncogenic Hepatocyte-Induced Orthotopic Mouse Model of Hepatocellular Cancer Arising in the Setting of Hepatic Inflammation and Fibrosis
Published on: September 12, 2019
Effects of Phytoadaptogen on Hepatoma Development in Cancer-Prone CBA Mice
O A Bocharova1, R V Karpova2, E V Bocharov2
1N. N. Blokhin Russian Cancer Research Center, Russian Academy of Medical Sciences, Moscow, Russia. imufarm@rambler.ru.
A complex phytoadaptogen reduced the occurrence, size, and number of liver cancers (hepatocarcinomas) in susceptible male mice. This natural compound showed both preventive and therapeutic effects against cancer development.
Area of Science:
- Oncology
- Pharmacology
- Natural Products
Background:
- Hepatocarcinomas pose a significant health challenge.
- Cancer-prone mouse models are crucial for studying carcinogenesis.
- Phytoadaptogens are natural compounds with potential health benefits.
Purpose of the Study:
- To investigate the efficacy of a complex phytoadaptogen in preventing and treating hepatocarcinomas.
- To evaluate the impact of phytoadaptogen treatment on liver cancer incidence, size, and number.
Main Methods:
- Utilized cancer-prone male CBA mice.
- Administered a complex phytoadaptogen as both a preventive and therapeutic agent.
- Monitored and quantified hepatocarcinoma development.
Main Results:
- Significant decrease in the incidence of hepatocarcinomas observed.
- Reduction in the average size of existing hepatocarcinomas.
- Lowered number of hepatocarcinomas per mouse in the treatment groups.
Conclusions:
- The complex phytoadaptogen demonstrated potent anti-hepatocarcinoma activity.
- Phytoadaptogen treatment is effective in both preventing and reducing liver cancer burden.
- These findings support the therapeutic potential of phytoadaptogens in oncology.
More Related Videos
09:03Establishment of Hepatocarcinoma in BALB/c-nu Mice and Investigation of the Therapeutic Effect of the Sanleng Jiashen Formula
Published on: January 26, 2024
04:12Chemical-Induced Skin Carcinogenesis Model Using Dimethylbenz[a]Anthracene and 12-O-Tetradecanoyl Phorbol-13-Acetate DMBA-TPA
Published on: December 19, 2019